Key result
5-fluorouracil chemotherapy caused sudden onset of severe cardiac failure in a 23-year-old patient, with biopsy showing sarcoplasmic reticulum proliferation and marked vacuolization.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
This case report highlights the potential for severe, non-ischemic heart failure induced by 5-fluorouracil, supported by endomyocardial biopsy findings.
The chemotherapeutic agent 5-fluorouracil (5-FU) is a widely accepted part of many cancer treatment protocols. Its cardiotoxic potential is known, but considered uncommon and usually not life threatening, although some cases of severe cardiotoxicity related to 5-FU have been reported. The pathogenesis of cardiotoxicity caused by 5-FU is not clear. We report a case of sudden onset of severe cardiac failure, without ischemic symptoms or signs, during 5-FU treatment with serious consequences, in a previously healthy 23-year-old patient with squamous cell carcinoma of the tongue. Endomyocardial biopsy showed proliferation of the sarcoplasmic reticulum with marked vacuolization, similar to that found with doxorubicin cardiotoxicity. Because 5-FU cardiotoxicity is unpredictable and can have potentially fatal consequences, it requires, in our opinion, further clarification. With this well-documented case, including an endomyocardial biopsy, we hope to encourage additional efforts to investigate the pathophysiologic mechanisms of 5-FU cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Kuropkat et al. (1999) conducted a case report in Squamous cell carcinoma of the tongue (n=1). 5-fluorouracil (5-FU) was evaluated. 5-fluorouracil chemotherapy caused sudden onset of severe cardiac failure in a 23-year-old patient, with biopsy showing sarcoplasmic reticulum proliferation and marked vacuolization.
Synapse has enriched 10 related papers. Consider them for comparative context: